Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review
Authors
Thomas J. Guzzo
Philip H. Abbosh (ORCID: https://orcid.org/0000-0003-3611-9532)
Ja Hyeon Ku (ORCID: https://orcid.org/0000-0002-0391-2342)
Girish S. Kulkarni (ORCID: https://orcid.org/0000-0002-6929-6124)
Mehmet Burcu (ORCID: https://orcid.org/0000-0003-4572-0987)
Carly A. Rodriguez (ORCID: https://orcid.org/0000-0003-0023-2111)
Julie Fox (ORCID: https://orcid.org/0000-0002-0583-8019)
Zachary Smith (ORCID: https://orcid.org/0000-0001-8221-1108)
M. Roumiguié (ORCID: https://orcid.org/0000-0002-2412-146X)
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review
Thomas J. Guzzo, Philip H. Abbosh, Ja Hyeon Ku, Girish S. Kulkarni et al.
Citations
3 citations
Journal
Clinical Genitourinary Cancer
Topics
Bladder and Urothelial Cancer Treatments
Field-Weighted Citation Impact (FWCI)
6.02
article
Real-World Treatment Patterns and Outcomes in Patients With Bacillus Calmette-Guérin–Unresponsive High-Risk Non–Muscle-Invasive Bladder Cancer: A Multicountry Medical Chart Review
Thomas J. Guzzo, Philip H. Abbosh, Ja Hyeon Ku, Girish S. Kulkarni, Mehmet Burcu, Carly A. Rodriguez, Julie Fox, Zachary Smith, M. Roumiguié, Ekta Kapadia, Abhishek Srivastava, William C. Huang, Ho Kyung Seo, Jean-Benoit Paradis, Romain Mathiéu, Joost L. Boormans, Neal D. Shore
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Clinical Genitourinary CancerVol. 23(3)
Institutions
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Fox Chase Cancer Center (US), Washington University in St. Louis (US), New Generation University College (ET), Princess Margaret Cancer Centre (CA), Cégep de Chicoutimi (CA), NYU Langone Health (US), Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean (CA), IQVIA (United States) (US), National Cancer Center (KR), Hôpital Rangueil (FR), Centre de Santé et de Services Sociaux de Chicoutimi (CA), Erasmus MC Cancer Institute (NL), IQ Solutions (US), Centre Hospitalier Universitaire de Rennes (FR), Carolina Urologic Research Center (US), University of Pennsylvania (US)
Funders
American Association for Cancer Research, Bristol-Myers Squibb, AstraZeneca, Bladder Cancer Advocacy Network, Natera, Astellas Pharma, EMD Serono, National Cancer Institute